Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor

被引:8
作者
Johnson, Mai [1 ,2 ]
Karanikolas, Breanne D. W. [1 ]
Priceman, Saul J. [1 ]
Powell, Russell [1 ]
Black, Margaret E. [3 ]
Wu, Hsiao-Ming [1 ]
Czernin, Johannes [1 ]
Huang, Sung-Cheng [1 ]
Wu, Lily [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Dept Mol & Medicalacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cellular & Integrat Physiol, Los Angeles, CA 90095 USA
[3] Washington State Univ, Dept Pharmaceut Sci, Pullman, WA 99164 USA
关键词
prostate cancer; thymidine kinase; PET; transgene expression; lentivirus; POSITRON-EMISSION-TOMOGRAPHY; HSV-TK GENE; REPORTER GENE; IN-VIVO; SUICIDE GENE; TRANSGENE EXPRESSION; CANCER; THERAPY; CELLS; ADENOVIRUS;
D O I
10.2967/jnumed.108.058438
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Because of its high selectivity and specificity for the imaging reporter probe 9-(4-F-18-fluoro-3-[hydroxymethyl] butyl) guanine (F-18-FHBG), the herpes simplex virus type 1 thymidine kinase (HSV1-tk) variant sr39tk is actively being studied as a PET reporter gene. We recently demonstrated the capability of using a prostate-specific transcriptional amplification PET reporter vector, AdTSTA-sr39tk, to target prostate cancer lymph node metastasis. However, one area that warrants further study is the examination of the sensitivity of PET by determining the minimum percentage of cells expressing the sr39tk transgene needed for detection. Addressing this question could determine the sensitivity of vector-mediated sr39tk PET in cancer-targeting strategies. Methods: DU-145, PC-3, and CWR22Rv.1 prostate cancer cell lines (a total of 1 x 10(6) cells) were studied, of which 7%, 10%, 25%, 50%, or 70% were transduced with the lentiviral vector constitutively expressing HSV1-sr39tk-IRES-enhanced green fluorescent protein (EGFP). Cells were subcutaneously implanted into the left shoulder of severe combined immunodeficient mice and evaluated. Tumor cells comparably transduced with an EGFP control vector were implanted on the right shoulder. Mice were imaged using PET with F-18-FHBG at 8, 15, and 22 d after tumor implant. On day 23, tumors were isolated and analyzed for sr39tk transgene expression by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry, and flow cytometry for EGFP expression. Results: Results showed a linear relationship between the level of sr39tk expression and the quantity of tracer accrual in DU-145, with the minimal value for PET detection at 10%. The magnitude of tracer retention in sr39tk-expressing cells was amplified over time as the tumor grew. Protein levels in the stepwise titration increased with the percentage of sr39tk-transduced cells. Conclusion: The stepwise titration of prostate cancer cells transduced with the lenti-CMV-sr39tk-IRES-EGFP determined the minimum number of sr39tk-expressing tumor cells necessary to be detected by PET using the F-18-FHBG reporter probe. Furthermore, PET signal correlated well with traditional methods of protein evaluation such as flow cytometry, quantitative RT-PCR, Western blotting, and immunohistochemistry. Unlike the traditional methods, however, the use of PET is noninvasive and will be more advantageous in clinical situations.
引用
收藏
页码:757 / 764
页数:8
相关论文
共 41 条
  • [1] Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG):: A new potential imaging agent for viral infection and gene therapy using PET
    Alauddin, MM
    Conti, PS
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) : 175 - 180
  • [2] [Anonymous], 2008, Cancer Facts Figures 2008
  • [3] Black ME, 2001, CANCER RES, V61, P3022
  • [4] Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer
    Burton, Jeremy B.
    Johnson, Mai
    Sato, Makoto
    Koh, Sok Boon S.
    Mulholland, David J.
    Stout, David
    Chatziioannou, Arion F.
    Phelps, Michael E.
    Wu, Hong
    Wu, Lily
    [J]. NATURE MEDICINE, 2008, 14 (08) : 882 - 888
  • [5] Positron emission tomography imaging of conditional gene activation in the heart
    Chang, Gwendolen Y.
    Cao, Feng
    Krishnan, Manickam
    Huang, Mei
    Li, Zongjin
    Xie, Xiaoyan
    Sheikh, Ahmad Y.
    Hoyt, Grant
    Robbins, Robert C.
    Hsial, Tzung
    Schneider, Michael D.
    Wu, Joseph C.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 43 (01) : 18 - 26
  • [6] INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS
    CULVER, KW
    RAM, Z
    WALLBRIDGE, S
    ISHII, H
    OLDFIELD, EH
    BLAESE, RM
    [J]. SCIENCE, 1992, 256 (5063) : 1550 - 1552
  • [7] In vivo molecular imaging characterizes pulmonary gene expression during experimental lung transplantation
    Dharmarajan, S
    Hayama, M
    Kozlowski, J
    Ishiyama, T
    Okazaki, M
    Factor, P
    Patterson, GA
    Schuster, DP
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) : 1216 - 1225
  • [8] Figueiredo Marxa L, 2006, Future Oncol, V2, P391
  • [9] How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
    Fischer, BM
    Olsen, MWB
    Ley, CD
    Klausen, TL
    Mortensen, J
    Hojgaard, L
    Kristjansen, PEG
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (06) : 697 - 702
  • [10] Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer
    Freytag, Svend O.
    Barton, Kenneth N.
    Brown, Stephen L.
    Narra, Vinod
    Zhang, Yingshu
    Tyson, Don
    Nall, Colleen
    Lu, Mei
    Ajlouni, Munther
    Movsas, Benjamin
    Kim, Jae Ho
    [J]. MOLECULAR THERAPY, 2007, 15 (09) : 1600 - 1606